An Australian biotech firm says it has successfully used precision fermentation to reproduce the most vital proteins in human ...
Regeneron teams up with Tessera to advance TSRA-196, aiming to correct the genetic cause of AATD as preclinical data support its move toward trials.
The protein, reverse transcriptase, has become an essential tool for making DNA copies of RNA.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback